rosiglitazone has been researched along with Sjogren's Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapsogeorgou, EK; Manoussakis, MN; Polyzos, A; Thanos, D; Vakrakou, AG | 1 |
| Li, X; Wang, Y; Wei, L; Xu, B | 1 |
2 other study(ies) available for rosiglitazone and Sjogren's Syndrome
| Article | Year |
|---|---|
Impaired anti-inflammatory activity of PPARγ in the salivary epithelia of Sjögren's syndrome patients imposed by intrinsic NF-κB activation.
Topics: Apoptosis; Cell Line; Disease Progression; Epithelium; Gene Expression Profiling; Gene Expression Regulation; Humans; Interleukin-1beta; NF-kappa B; PPAR gamma; Rosiglitazone; Salivary Glands; Signal Transduction; Sjogren's Syndrome; Tissue Array Analysis | 2018 |
Anti-inflammatory effect of peroxisome proliferator-activated receptor-γ (PPAR-γ) on non-obese diabetic mice with Sjogren's syndrome.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Hypoglycemic Agents; Immunohistochemistry; Mice; Mice, Inbred NOD; PPAR gamma; Real-Time Polymerase Chain Reaction; Rosiglitazone; Sjogren's Syndrome; Thiazolidinediones | 2014 |